共有 1 页
品牌 | 货号 | 包装单位 | 货期 | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|
罗恩 | R022807-25mg | 25mg | 5~7个工作日 |
4-氨基-N-[(1S)-1-(4-氯苯基)-3-羟基丙... AZD5363 |
98% |
|
|
罗恩 | R022807-5mg | 5mg | 5~7个工作日 |
4-氨基-N-[(1S)-1-(4-氯苯基)-3-羟基丙... AZD5363 |
98% |
|
|
阿拉丁 | A128036-5mg | 5mg | 现货 |
AZD5363,泛泛AKT抑制剂 AZD5363 |
Moligand™, ≥98% |
|
|
阿拉丁 | A128036-25mg | 25mg | 现货 |
AZD5363,泛泛AKT抑制剂 AZD5363 |
Moligand™, ≥98% |
|
|
阿拉丁 | A128036-100mg | 100mg | 现货 |
AZD5363,泛泛AKT抑制剂 AZD5363 |
Moligand™, ≥98% |
|
|
阿拉丁 | A128036-50mg | 50mg | 现货 |
AZD5363,泛泛AKT抑制剂 AZD5363 |
Moligand™, ≥98% |
|
|
阿拉丁 | C408664-1ml | 1ml | 现货 |
Capivasertib (AZD5363) Capivasertib (AZD5363) |
Moligand™, 10mM in DMSO |
|
|
凯为 | JZ000C4S-10mg | 10mg | 现货 |
(S)-4-氨基-N-(1-(4-氯苯基)-3-羟基丙基... 4-Piperidinecarboxamide, 4-a... |
98% |
|
|
凯为 | JZ000C4S-50mg | 50mg | 现货 |
(S)-4-氨基-N-(1-(4-氯苯基)-3-羟基丙基... 4-Piperidinecarboxamide, 4-a... |
98% |
|
|
凯为 | JZ000C4S-100mg | 100mg | 现货 |
(S)-4-氨基-N-(1-(4-氯苯基)-3-羟基丙基... 4-Piperidinecarboxamide, 4-a... |
98% |
|
|
凯为 | JZ000C4S-250mg | 250mg | 现货 |
(S)-4-氨基-N-(1-(4-氯苯基)-3-羟基丙基... 4-Piperidinecarboxamide, 4-a... |
98% |
|
|
凯为 | JZ000C4S-1g | 1g | 现货 |
(S)-4-氨基-N-(1-(4-氯苯基)-3-羟基丙基... 4-Piperidinecarboxamide, 4-a... |
98% |
|
|
凯为 | JZ000C4S-5mg | 5mg | 现货 |
(S)-4-氨基-N-(1-(4-氯苯基)-3-羟基丙基... 4-Piperidinecarboxamide, 4-a... |
98% |
|
|
凯为 | JZ000C4S-25mg | 25mg | 现货 |
(S)-4-氨基-N-(1-(4-氯苯基)-3-羟基丙基... 4-Piperidinecarboxamide, 4-a... |
98% |
|
|
毕得 | BD287252-5mg | 5mg | 现货 |
(S)-4-氨基-N-(1-(4-氯苯基)-3-羟丙基)... (S)-4-Amino-N-(1-(4-chloroph... |
98% |
|
|
毕得 | BD287252-10mg | 10mg | 现货 |
(S)-4-氨基-N-(1-(4-氯苯基)-3-羟丙基)... (S)-4-Amino-N-(1-(4-chloroph... |
98% |
|
|
毕得 | BD287252-50mg | 50mg | 现货 |
(S)-4-氨基-N-(1-(4-氯苯基)-3-羟丙基)... (S)-4-Amino-N-(1-(4-chloroph... |
98% |
|
|
毕得 | BD287252-100mg | 100mg | 现货 |
(S)-4-氨基-N-(1-(4-氯苯基)-3-羟丙基)... (S)-4-Amino-N-(1-(4-chloroph... |
98% |
|
|
毕得 | BD287252-1mg | 1mg | 现货 |
(S)-4-氨基-N-(1-(4-氯苯基)-3-羟丙基)... (S)-4-Amino-N-(1-(4-chloroph... |
98% |
|
|
毕得 | BD287252-250mg | 250mg | 现货 |
(S)-4-氨基-N-(1-(4-氯苯基)-3-羟丙基)... (S)-4-Amino-N-(1-(4-chloroph... |
98% |
|
|
毕得 | BD287252-1g | 1g | 现货 |
(S)-4-氨基-N-(1-(4-氯苯基)-3-羟丙基)... (S)-4-Amino-N-(1-(4-chloroph... |
98% |
|
|
毕得 | BD287252-25mg | 25mg | 现货 |
(S)-4-氨基-N-(1-(4-氯苯基)-3-羟丙基)... (S)-4-Amino-N-(1-(4-chloroph... |
98% |
|
|
韶远 | SY018928-0.1g | 0.1g | 现货 |
(S)-1-(7H-吡咯并[2,3-d]嘧啶-4-基)-... (S)-4-Amino-N-[1-(4-chloroph... |
>97% |
|
|
韶远 | SY018928-0.25g | 0.25g | 现货 |
(S)-1-(7H-吡咯并[2,3-d]嘧啶-4-基)-... (S)-4-Amino-N-[1-(4-chloroph... |
>97% |
|
|
韶远 | SY018928-1g | 1g | 现货 |
(S)-1-(7H-吡咯并[2,3-d]嘧啶-4-基)-... (S)-4-Amino-N-[1-(4-chloroph... |
>97% |
|
|
百灵威 | JK1561522-5MG | 5MG | 4-6周 |
AZD5363, 一种有效的 pan-AKT 激酶抑制剂 AZD5363, 99%, a potent pan-A... |
99% |
|
|
TRC | A808135-1mg | 1mg | 期货,请咨询 |
4-氨基-N-[(1S)-1-(4-氯苯基)-3-羟基丙... AZD5363 |
>95% |
|
|
TRC | A808135-5mg | 5mg | 期货,请咨询 |
4-氨基-N-[(1S)-1-(4-氯苯基)-3-羟基丙... AZD5363 |
>95% |
|
|
源叶 | S81216-1mg | 1mg | 现货 |
AZD5363 4-Piperidinecarboxamide, 4-a... |
97% |
|
|
源叶 | S81216-2mg | 2mg | 现货 |
AZD5363 4-Piperidinecarboxamide, 4-a... |
97% |
|
|
源叶 | S81216-5mg | 5mg | 现货 |
AZD5363 4-Piperidinecarboxamide, 4-a... |
97% |
|
|
源叶 | S81216-10mg | 10mg | 现货 |
AZD5363 4-Piperidinecarboxamide, 4-a... |
97% |
|
|
源叶 | S81216-25mg | 25mg | 现货 |
AZD5363 4-Piperidinecarboxamide, 4-a... |
97% |
|
|
源叶 | S81216-50mg | 50mg | 现货 |
AZD5363 4-Piperidinecarboxamide, 4-a... |
97% |
|
|
源叶 | S81216-100mg | 100mg | 现货 |
AZD5363 4-Piperidinecarboxamide, 4-a... |
97% |
|
|
源叶 | T93096-1ml | 1ml | 期货,请咨询 |
Capivasertib (AZD5363) Capivasertib (AZD5363) |
10mM in DMSO |
|
|
Target Mol | T1920-1mg | 1mg | 现货 |
化合物 Capivasertib Capivaserti |
99.6% |
|
|
Target Mol | T1920-5mg | 5mg | 现货 |
化合物 Capivasertib Capivaserti |
99.6% |
|
|
Target Mol | T1920-10mg | 10mg | 现货 |
化合物 Capivasertib Capivaserti |
99.6% |
|
|
Target Mol | T1920-25mg | 25mg | 现货 |
化合物 Capivasertib Capivaserti |
99.6% |
|
|
Target Mol | T1920-50mg | 50mg | 现货 |
化合物 Capivasertib Capivaserti |
99.6% |
|
|
Target Mol | T1920-100mg | 100mg | 现货 |
化合物 Capivasertib Capivaserti |
99.6% |
|
|
Target Mol | T1920-1mL | 1mL | 现货 |
化合物 Capivasertib Capivaserti |
99.6% |
|
|
Target Mol | T1920-500mg | 500mg | 现货 |
化合物 Capivasertib Capivaserti |
99.6% |
|
|
Am | A260907-10mg | 10mg | 现货 |
Capivasertib Capivaserti |
98% |
|
|
Am | A260907-50mg | 50mg | 现货 |
Capivasertib Capivaserti |
98% |
|
|
Am | A260907-100mg | 100mg | 现货 |
Capivasertib Capivaserti |
98% |
|
|
Am | A260907-1mg | 1mg | 现货 |
Capivasertib Capivaserti |
98% |
|
|
Am | A260907-5mg | 5mg | 现货 |
Capivasertib Capivaserti |
98% |
|
|
MCE | HY-15431-100mg | 100mg | 现货 |
Capivasertib Capivaserti |
99.95% |
|
|
MCE | HY-15431-50mg | 50mg | 现货 |
Capivasertib Capivaserti |
99.95% |
|
|
MCE | HY-15431-10mg | 10mg | 现货 |
Capivasertib Capivaserti |
99.95% |
|
|
MCE | HY-15431-10mM*1mL | 10mM*1mL | 现货 |
Capivasertib Capivaserti |
99.95% |
|
|
MCE | HY-15431-5mg | 5mg | 现货 |
Capivasertib Capivaserti |
99.95% |
|
|